Published in Infect Immun on July 10, 2017
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Citrobacter rodentium of mice and man. Cell Microbiol (2005) 4.76
Pro-resolving lipid mediators are leads for resolution physiology. Nature (2014) 4.15
Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature (2012) 4.04
Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev (2010) 3.31
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature (2009) 3.27
Control of pathogens and pathobionts by the gut microbiota. Nat Immunol (2013) 2.84
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med (1994) 2.53
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut (2003) 2.37
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun (2004) 2.32
Acute bacterial meningitis in infants and children. Lancet Infect Dis (2010) 2.30
Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination. Cell Host Microbe (2015) 2.29
Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol (2011) 2.17
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol (2004) 2.02
Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity (2014) 1.85
Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Opin Gastroenterol (2008) 1.77
Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.75
The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol (2009) 1.71
Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med (2015) 1.71
Minireview: clinical cryptosporidiosis. Exp Parasitol (2009) 1.62
Morphology of rectal mucosa of patients with shigellosis. Rev Infect Dis (1991) 1.60
Innate cellular immune responses in newborns. Clin Immunol (2005) 1.57
Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol (2014) 1.54
The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. Microb Pathog (1988) 1.53
Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci U S A (2012) 1.49
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol (2015) 1.34
Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine (2010) 1.20
The developing immune system - from foetus to toddler. Acta Paediatr (2011) 1.18
Virulence markers of enteroaggregative Escherichia coli isolated from children and adults with diarrhea in Brasília, Brazil. J Clin Microbiol (2003) 1.11
Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema. Br J Dermatol (2013) 1.10
The resolution of inflammation: Principles and challenges. Semin Immunol (2015) 1.09
High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis (2013) 1.08
Immune responses in neonates. Expert Rev Clin Immunol (2014) 1.06
Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock (2011) 1.06
Characteristics and functional capacities of human cord blood granulocytes and monocytes. Pediatr Res (1984) 1.02
Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov (2016) 1.02
Phagocytic ability of neutrophils and monocytes in neonates. BMC Pediatr (2011) 1.01
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol (2015) 0.99
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Immunol (2012) 0.99
Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. FASEB J (2015) 0.98
Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis (2010) 0.97
Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward. Trends Microbiol (2013) 0.95
Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis (2012) 0.95
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life. J Immunol (2015) 0.95
Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein-labeled Escherichia coli and group B Streptococci. Cytometry B Clin Cytom (2009) 0.94
Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci. Infect Immun (1991) 0.92
Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol (2015) 0.91
Murine neonates are highly resistant to Yersinia enterocolitica following orogastric exposure. Infect Immun (2007) 0.89
New insights into the resolution of inflammation. Semin Immunol (2015) 0.88
A new method to quantify phagocytosis and intracellular degradation using green fluorescent protein-labeled Escherichia coli: comparison of cord blood macrophages and peripheral blood macrophages of healthy adults. Cytometry A (2006) 0.85
Etiology of Childhood Infectious Diarrhea in a Developed Region of China: Compared to Childhood Diarrhea in a Developing Region and Adult Diarrhea in a Developed Region. PLoS One (2015) 0.84
Vaccination in early life: standing up to the challenges. Curr Opin Immunol (2016) 0.84
Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance. Sci Rep (2016) 0.82
Infants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life. BMC Pediatr (2014) 0.81
Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. Mucosal Immunol (2015) 0.81
Murine neonates infected with Yersinia enterocolitica develop rapid and robust proinflammatory responses in intestinal lymphoid tissues. Infect Immun (2013) 0.81
THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM. Eur J Microbiol Immunol (Bp) (2011) 0.81
Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Chest (2016) 0.80
An update on the microbiology and epidemiology of enteropathogenic Escherichia coli in England 2010-2012. J Med Microbiol (2013) 0.80
Resolvin D3 multi-level proresolving actions are host protective during infection. Prostaglandins Leukot Essent Fatty Acids (2016) 0.80
Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice. PLoS Pathog (2016) 0.79
Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens. Science (2017) 0.79
Novel Resolvin D2 Receptor Axis in Infectious Inflammation. J Immunol (2016) 0.77
Neonatal Vaccination: Challenges and Intervention Strategies. Neonatology (2016) 0.77
Cryptosporidium parvum increases intestinal permeability through interaction with epithelial cells and IL-1β and TNFα released by inflammatory monocytes. Cell Microbiol (2016) 0.76
Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection. Front Immunol (2016) 0.75
Alterations in neonatal neutrophil function attributable to increased immature forms. Early Hum Dev (2016) 0.75